This platform demonstrates rapid detection of the microcystin gene in lake water, highlighting the impact on harmful algal blooms.
Microcystins are potent cyanotoxins produced by toxigenic cyanobacteria during harmful algal blooms (HABs), posing risks to ecosystems and human health. In this study, we developed a portable RPA-CRISPR/Cas12a biosensing platform for the rapid, on-site detection of the microcystin synthetase E (mcyE) gene, a key biomarker for microcystin-producing strains. The developed RPA-CRISPR/Cas12a assays enable detection of the mcyE gene within 50 min, with either fluorescence or lateral flow assay readout. The fluorescence readout has an analytical detection limit of 1.2 × 102 copies/μL and a dynamic range of 1.2 × 102 to 1.2 × 107 copies/μL. To enable field deployment, a magnetic bead-based DNA extraction method was integrated, achieving extraction within 1 h without centrifugation. The complete workflow demonstrated a method LOD of 1.9 × 103 cells/mL in spiked lake water. Applicability was validated using nonspiked environmental water samples collected from multiple HAB-affected lakes. Importantly, a systematic matrix effect assessment was conducted for the CRISPR sensing step, evaluating environmental variables such as pH, ions, nutrients, and natural organic matter. This study establishes a practical, sensitive, and selective detection tool for proactive HAB monitoring. The platform's simplicity, portability, and completeness, from sample pretreatment to signal readout, highlight its potential for real-world environmental biosensing applications.
No takes yet. Share an insight, caveat, or question.
Hasan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: